In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the metastases. However, little is known about ER expression across metastases throughout the body and surrounding ...
Aug 6, 2018
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved ribociclib (Kisqali) in combination with an aromatase inhibitor (AI) as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal ...
Jul 24, 2018
0
2
Membrane-associated metalloprotease, MMP14, plays a significant role in different cancer tissues – for instance in breast cancer and melanoma patients high MMP14 levels increase the risk to develop metastasis. The study, ...
Jun 26, 2018
0
0
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient ...
Jun 4, 2018
0
874
Findings from a major international clinical trial suggest a significant number of women with the most common form of early-stage breast cancer do not need chemotherapy after surgery.
Jun 4, 2018
0
1
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.
May 18, 2018
0
122
A new study indicates that parenting concerns are associated with poor health-related quality of life among women with metastatic cancer who are parents of dependent children. Published early online in Cancer, a peer-reviewed ...
May 7, 2018
0
5
Tagworks Pharmaceuticals, based at Radboud University Medical Center, has developed a new technique for the targeted delivery of chemotherapy for tumors in difficult cases. By way of controlled 'click-to-release' of the chemotherapy ...
May 4, 2018
1
23
Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies.
Apr 18, 2018
0
44
A multi-institutional research team has identified what may be a novel mechanism underlying acquired resistance to CDK 4/6 inhibitor treatment for breast cancer. In their report published in the Annals of Oncology, the team—led ...
Apr 11, 2018
0
5
